Tattoo ink doesn’t just sit inertly in the skin. New research shows it moves rapidly into the lymphatic system, where it can ...

To get a sense of who is truly in control of Pfizer Inc. (NYSE:PFE), it is important to understand the ownership structure of ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer Inc. (NYSE:PFE) is one of the best low volatility large cap stocks to invest in. On November 24, Guggenheim lifted the ...

Three cancer therapies were among the first two batches of drugs to receive vouchers through a new FDA program.

Most of the dividend increases announced in the last two weeks of November were in the low-to-mid single-digit percentages.

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

In the ever-evolving landscape of the biopharmaceutical industry, Pfizer Inc. (NYSE:PFE) has emerged as a noteworthy player, particularly for investors seeking stability. Recently, Guggenheim raised ...

These five stocks are potential total return champions that could offer investors a smooth ride in 2026, as we could see some ...

Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the U.S. healthcare system, especially ...

A top biotech fund just made a bold move while Celcuity trades near record highs—here’s what they might see coming next.

A U.S. appeals court on Tuesday overturned a nearly $42 million jury verdict won by Pfizer's Seagen against Japanese rival drugmaker Daiichi Sankyo over allegations that Daiichi and AstraZeneca's ...